USER GUIDE
V1.0
REMOTE CARE PARTNERS
PAGE 43
Comparison Options:
The Contour next ONE
system is designed for use with capillary whole
blood. Comparison with a laboratory method
must be done simultaneously with aliquots of the
same sample.
NOTE:
Glucose concentrations drop rapidly due
to glycolysis
(approximately 5%
–
7% per hour).
7
REFERENCES
1.
US Food and Drug Administration. Use of fingerstick
devices on more than one person poses risk for
transmitting bloodborne pathogens: initial
communication. US Department of Health and
Human Services; update 11/29/2010.
http://www.fda.gov/MedicalDevices/Safety/Alerts
andNotices/ ucm224025.htm
2.
Centers for Disease Control and Prevention. CDC
clinical reminder: use of fingerstick devices on more
than one person poses risk for transmitting
bloodborne pathogens. US Department of Health
and Human Services; 8/23/2010.
http://www.cdc.gov/injectionsafety/FingerstickDevic
esBGM.html
3.
Wickham NWR, et al. Unreliability of capillary blood
glucose in peripheral vascular disease.
Practical
Diabetes
. 1986;3(2):100.
4.
Atkin SH, et al. Fingerstick glucose determination in
shock.
Annals of Internal Medicine
.
1991;114(12):1020-1024.
5.
Desachy A, et al. Accuracy of bedside glucometry
in critically ill patients: influence of clinical
